The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Occult hepatitis B virus infection and its clinical implications
Abstract
Occult hepatitis B virus (HBV) infection is characterized by presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg). Serum HBV level is usually less than 10 4 copies/mL in these patients. Diagnosis of occult HBV infection requires sensitive HBV‐DNA PCR assay. Several possibilities have been hypothesized as the mechanisms of occult HBV infection. These include: (i) mutations of HBV‐DNA sequence; (ii) integration of HBV‐DNA into host's chromosomes; (iii) infection of peripheral blood mononuclear cells by HBV; (iv) formation of HBV‐containing immune complex; (v) altered host immune response; and (vi) interference of HBV by other viruses. The precise prevalence of occult HBV infection remains to be defined. The clinical implications of occult HBV infection involve different clinical aspects. First of all, occult HBV infection harbours potential risk of HBV transmission through blood transfusion, haemodialysis, and organ transplantation. Second, it may serve as the cause of cryptogenic liver disease, contribute to acute exacerbation of chronic hepatitis B, or even fulminant hepatitis. Third, it is associated with development of hepatocellular carcinoma. Fourth, it may affect disease progression and treatment response of chronic hepatitis C. Most of the previous studies utilized retrospective observation without control groups, and lacked direct association of occult HBV infection with specific pathological changes and disease progression. Highly sensitive, quantitative, and functional molecular analyses of HBV, combined with a well‐designed prospective clinical assessment will provide the best approach for the future study of occult HBV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Vaccine-induced escape mutant of hepatitis B virus
Carman, W. F., Karayiannis, P., Waters, J., Thomas, H. C., Zanetti, A. R., Manzillo, G., & Zuckerman, A. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91874-a · Cited by 1,074
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Kao, J., Chen, P., Lai, M., & Chen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70261-7 · Cited by 925
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease
Cacciola, I., Pollicino, T., Squadrito, G., Cerenzia, G., Orlando, M. E., & Raimondo, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410104 · Cited by 666
Bréchot, C., Thiers, V., Kremsdorf, D., Nalpas, B., Pol, S., & Paterlini-Bréchot, P. (2001) · Hepatology · doi:10.1053/jhep.2001.25172 · Cited by 560
Bréchot, C., Degos, F., Lugassy, C., Thiers, V., Zafrani, S., Franco, D., Bismuth, H., Trépo, C., Benhamou, J.-P., Wands, J., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501313120503 · Cited by 459
Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen
Hoofnagle, J. H., Seeff, L. B., Buskell‐Bales, Z., Zimmerman, H. J., & the Veterans Administration Hepatitis Cooperative Study Group* (1978) · New England Journal of Medicine · doi:10.1056/nejm197806222982502 · Cited by 458
Cited by
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J.-P., Brunetto, M. R., Buendia, M.-A., Chen, D.-S., Colombo, M., Craxì, A., Donato, F., Ferrari, C., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 833
Control of cccDNA function in hepatitis B virus infection
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.022 · Cited by 552
Occult hepatitis B virus infection
Raimondo, G., Pollicino, T., Cacciola, I., & Squadrito, G. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.007 · Cited by 543
Bart, G., Piccolo, P., Zhang, L., Jacobson, I., Schaefer, R. A., & Kreek, M. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02151.x · Cited by 25
Metadata
- Authors
- Hu, K.
- Venue
- Journal of Viral Hepatitis
- Publisher
- Wiley
- Published
- 2002-06-25
- Volume
- 9
- Issue
- 4
- Pages
- 243-257
- ISSN
- 1352-0504 (ISSN-L)
- 1365-2893
- OpenAlex
- W1970122218
- Cited by
- 280
- References
- 62
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Occult hepatitis B virus infection and its clinical implications. https://app.cochat.ai/papers/10.1046/j.1365-2893.2002.00344.x
- The paper
- Hu, K. (2002). Occult hepatitis B virus infection and its clinical implications. Journal of Viral Hepatitis. https://doi.org/10.1046/j.1365-2893.2002.00344.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.